[Risk factors of side effects of antituberculosis drugs]. 2006

Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
Service de pneumologie, Hôpital Charles Nicolle de Tunis.

The aim of this study was to determine the side effects of standard antituberculosis therapy with isoniazid, rifampicin, pyrazinamide and streptomycine in patients treated for tuberculosis. One hundred eighty nine patients with proven tuberculosis, who initially received standard antituberculosis therapy, were retrospectively studied. Begaud and coll's method of side effects drugs imputability elaborated in 1999 was used in our study. Side effects related to therapy were present in 31.7% of the studied population. Gastrointestinal side effect was the most common (13.2%), isoniazid, rifampicin and pyrazinamide were often incriminated. The significant risk factors of hepatotoxicity were female gender (OR : 10.59) and concomitant hepatotoxic drugs (OR 6). Chocleovestibular toxicity was associated significantly with female gender (OR : 8.03) and diabetes mellitus (OR : 6.13). Patients aged above 50, proved to be at risk for pyrazinomide intolerance and females for streptomycine. The study did not reveal any susceptibility to isoniazid and rifadine intolerance.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
April 2004, American journal of respiratory and critical care medicine,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
June 1986, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
December 1979, Chest,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
February 1996, Lancet (London, England),
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
October 1990, Journal of the Indian Medical Association,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
January 1997, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
December 2001, Thorax,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
February 2004, American journal of respiratory and critical care medicine,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
May 2004, American journal of respiratory and critical care medicine,
Leila El Gharbi, and Mohamed Ali Baccar, and Saloua Azzabi, and Hichem Aouina, and Houda Kallel, and Riadh Daghfous, and Hend Bouacha
January 2015, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia,
Copied contents to your clipboard!